Abstract:PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is the 4 leading cause of U.S. cancer-related mortality. Currently, patients with PDAC have a dismal prognosis due to a complete lack of effective therapies . Dendritic cells (DC) are one of the most potent antigen-presenting cells (APCs) in the immune system. Development of therapeutic cancer vaccines using DCs loaded with tumor antigens which are transferred to a host enhancing its tumor immune response, is a viable treatment option, however clinical trials have failed to achieve good efficacy. One of the major roadblocks to the development of these immune therapies is the inability to assess effective target acquisition. In this work we demonstrate that ironoxide labeled DCs, loaded with antigens, can be effectively tracked as they “home in” on the lymph nodes 3 . By providing direct MR visualization of DC uptake in lymph node environment one can positively confirm target acquisition and explore the underlying mechanisms more in depth, The research conducted in this work will the development of these cancer vaccines for translational applications METHODS Panc-2 tumor cells (~2 × 10 cells ) were implanted in both right and left flank female C57BL/6 mice and allowed to grow to palpable nodule (~3-5 mm). Bone marrow derived DCs were prepared as described in [1]. After antigen loading as described in [23] DCs were labeled with biocompatible iron nanoparticles FeOLabel-TexasRed (GENOVIS AB, Lund Sweden) as prescribed. Characterization was conducted to evaluate percent of iron and viability of labeled DCs. Iron amount was estimated by MR relaxometry using variable concentration phantoms (0-10 μg/ml). Vaccine administration was performed by injecting the labeled DCs in the left hind footpad of the mice (Three groups: 1) 1e6 cells, 2) 2e6 cells and 3) no cells as control) All MRI experiments (in vitro and ex vivo) were carried out on a Bruker 7 T (Clinscan, Ettlingen, Germany) using multiple spin echo and multiple gradient echo sequences to obtain coronal and axial images of the bilateral popliteal LNs and to generate corresponding parametric maps (Slice Thickness=0.2 mm In plane resolution 0.14 mm) . Animals were scanned at 6 hours and 24 hours after injection of DCs. All physiological parameters were maintained during experiments as prescribed by institutional ACUC standards. Ex vivo assessment of DC loading in popliteal LN was conducted using histological methods for validation of MRI images. Anti-Tumor efficacy of DCs was evaluated using standard vital signs and by measuring tumor volume at different time points following tumor implantation (1,5,10,15,20,25,35 days). RESULTS & DISCUSSION: Shown in Figure 1(a-c) are three coronal T2W images of bilateral popliteal LN’s at different times (a) preinjection of DC’s, (b) 6 hour post and (c) 24 hour post. The left LN exhibits clear signal decrease consistent with migration of iron labeled DC’s (injected in left footpad) while right is unaffected. Prussian blue staining of bilateral popliteal LNs are shown in Fig 1 (d) Right and Fig 1(e) Left, confirming presence of SPIO labeled DC’s in the later (Fig 1(f) is a blow up of region). Also shown in Fig 2 are the tumor size longitudinal measurements for control group compared to group A (1e6 DC’s) and group B (2e6 DC’s) demonstrating the therapeutic efficacy of the treatment

MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models

Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles

Targeting Pancreatic Cancer with Magneto-Fluorescent Theranostic Gold Nanoshells.

Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer

PCN-Fe(III)-PTX Nanoparticles for MRI Guided High Efficiency Chemo-Photodynamic Therapy in Pancreatic Cancer Through Alleviating Tumor Hypoxia

Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts

Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.

A collagenase-decorated Cu-based nanotheranostics: remodeling extracellular matrix for optimizing cuproptosis and MRI in pancreatic ductal adenocarcinoma

Ultrasound-targeted microbubble destruction improves the suppression and magnetic resonance imaging of pancreatic cancer with polyethyleneimine nanogels

Optical Magnetic Multimodality Imaging of Plectin-1-targeted Imaging Agent for the Precise Detection of Orthotopic Pancreatic Ductal Adenocarcinoma in Mice.

A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors.

Development of Peptide Conjugated Superparamagnetic Iron Oxide (SPIO) Nanoparticles for Targeted MR Imaging and Therapy of Pancreatic Cancer

Multimodal Targeted Nanoparticle-Based Delivery System for Pancreatic Tumor Imaging in Cellular and Animal Models.

Multiomic analysis for optimization of combined focal and immunotherapy protocols in murine pancreatic cancer

Molecular Imaging of Pancreatic Cancer in an Animal Model Using Targeted Multifunctional Nanoparticles.

EGFR-targeted Liposomal Nanohybrid Cerasomes: Theranostic Function and Immune Checkpoint Inhibition in a Mouse Model of Colorectal Cancer.

TME-responsive nanoplatform for multimodal imaging-guided synergistic precision therapy of esophageal cancer via inhibiting HIF-1α signal pathway

Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy

Optical Magnetic Multimodality Imaging of Plectin-1-Targeted Imaging Agent for the Precise Detection of Orthotopic Pancreatic Adenocarcinoma

Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer models

6617 In vivo cellular MRI monitoring of FeO Labeled DC-based cancer vaccine for immunotherapeutic treatment of pancreatic cancer